Tag: MYCO.NEO
-
![Mydecine Innovations (MYCO.NEO) is operating on the leading edge of mental health & addiction treatment]()
Mydecine Innovations (MYCO.NEO) is operating on the leading edge of mental health & addiction treatment
On February 16, 2022 Mydecine Innovations Group (MYCO.NEO) announced the inclusion of a novel molecule with potentially heart-safe microdose enabling properties in their family of psilocin analogs. Founded in 2020, Mydecine Innovations is a biotechnology company developing therapeutics to treat unmet needs in mental health and addiction disorders. Focusing on psychedelic compounds with therapeutic potential,…
